CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
28th May 2026 Uncategorised 0The top pharmacy benefit manager in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, allowing a significant number of patients to gain access to the drugs through their existing insurance.
More: CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
Source: fierce
